Washington, DC – December 12, 2019 – Friends of Cancer Research (Friends) would like to thank the Senate for doing what is right by patients and confirming Dr. Stephen Hahn as FDA commissioner by a vote of 72-18.
“The U.S. is at an inflection point for science and innovation,” said Friends’ Chair and Founder Ellen Sigal. “Dr. Hahn has a strong focus on advancing and improving the public health. His experience has prepared him to bolster the FDA’s important work that directly impacts patients’ lives.”
Friends looks forward to working with Dr. Hahn and the FDA to continue and expand the vital work that both Former Commissioner Gottlieb and Dr. Sharpless set forth.